Rezolute, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 9/06/2017
Contact Info
  • 1450 Infinite Drive
  • Louisville, CO 80027

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2017 10-Q
CIK 0001509261
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2010
Employees 48 a/o Sep 05, 2017
Company Officers/Contacts
Nevan C. Elam CEO
Hoyoung Huh Business Development
Noopur Liffick SVP, Corp. Dev.
Morgan Fields Chief Accounting Officer
Sankaram Mantripragada Chief Scientific Officer
Tae Hoon Kim Outside Director
Barry M. Sherman Outside Director
David Welch Outside Director
Samir R. Patel Outside Director
Company Directors
Nevan C. Elam Chairman
Hoyoung Huh
Company Notes
  • Formerly=AntriaBio, Inc. until 12-2017
  • Formerly=Fits My Style, Inc. until 1-2013
Service Providers
Accounting/Auditing Firm
7979 E. Tufts Ave.
Suite 400
Denver, CO, 80237
United States

Legal Counsel
Dorsey & Whitney LLP
1400 Wewatta Street
Suite 400
Denver, CO, 80202
United States

Investor Relations Firm
Not Available
RZLT Security Details
Share Structure
Market Value1 $51,339,276 a/o Jan 22, 2018
Authorized Shares 220,000,000 a/o Jan 02, 2018
Outstanding Shares 57,043,640 a/o Jan 02, 2018
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 35,448,145 a/o Dec 30, 2016
Par Value 0.001
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders of Record 379 a/o Sep 22, 2017
Short Selling Data
Short Interest 1,650 (-42.19%)
Oct 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security